{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:07:27Z","timestamp":1779214047909,"version":"3.51.4"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["MHN DTP - 223508\/Z\/21\/Z"],"award-info":[{"award-number":["MHN DTP - 223508\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019663","name":"Institute for Advanced Computer Studies, University of Maryland","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100019663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore the anticipated acceptability of bacteriophage therapy for recurrent urinary tract infections (rUTIs) among key stakeholders in the United Kingdom, using the Theoretical Framework of Acceptability (TFA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Qualitative study using online focus groups, analysed with reflexive thematic analysis, and mapped to the constructs of the TFA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>United Kingdom, conducted online via Microsoft Teams.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Forty-four participants across three stakeholder groups: individuals with lived experience of rUTIs, doctors involved in UTI management, and other healthcare professionals (HCPs: specialist nurses, pharmacists, and advanced care practitioners).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants demonstrated high enthusiasm for phage therapy, reflecting positive affective attitude and strong perceptions of effectiveness. For patients with lived experience, enthusiasm was often grounded in desperation following repeated treatment failure, raising ethical concerns around vulnerability to poor-quality research or inequitable access. Across groups, opportunity costs were identified as key barriers, centred on financial impact and availability within the NHS. Gaps in understanding about mechanisms, safety, and delivery highlighted the importance of intervention coherence and, for doctors and other HCPs, self-efficacy. Lived experience participants described strong online communities that acted as informal knowledge networks, suggesting a potential channel for dissemination and education.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec006\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Phage therapy was broadly viewed as acceptable, but acceptability is conditional on evidence of safety and effectiveness, equitable access, and clear communication. Application of the TFA demonstrated how enthusiasm, vulnerability, cost, and coherence intersect to shape overall perceptions. These findings emphasise the importance of ethical safeguards, patient-centred education, and integration with community networks to support the responsible adoption of phage therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0349568","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:22:08Z","timestamp":1779211328000},"page":"e0349568","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phage therapy for recurrent urinary tract infections: A qualitative study using the theoretical framework of acceptability"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3437-0785","authenticated-orcid":true,"given":"David","family":"Wenzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Crick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7356-5342","authenticated-orcid":true,"given":"Carolyn","family":"Tarrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Revitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeni","family":"Senior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Haines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"1","key":"pone.0349568.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden","volume":"28","author":"B Foxman","year":"2014","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"pone.0349568.ref002","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1067\/mda.2003.7","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"49","author":"B Foxman","year":"2003","journal-title":"Dis Mon"},{"key":"pone.0349568.ref003","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMcp1503950","article-title":"Urinary Tract Infections in Older Men","volume":"374","author":"AJ Schaeffer","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0349568.ref004","first-page":"40","article-title":"Urinary tract infection in women","volume":"20","author":"K Czajkowski","year":"2021","journal-title":"Prz Menopauzalny"},{"key":"pone.0349568.ref005","author":"National Institute for Health and Care Excellence (NICE)","year":"2025"},{"issue":"12","key":"pone.0349568.ref006","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/oxfordjournals.aje.a010170","article-title":"Risk factors for second urinary tract infection among college women","volume":"151","author":"B Foxman","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"7","key":"pone.0349568.ref007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236036","article-title":"Changes in the vaginal microbiota following antibiotic treatment for Mycoplasma genitalium, Chlamydia trachomatis and bacterial vaginosis","volume":"15","author":"P Ahrens","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"pone.0349568.ref008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.urols.2013.11.007","article-title":"Recurrent urinary tract infections in healthy and nonpregnant women","volume":"25","author":"M Glover","year":"2014","journal-title":"Urol Sci"},{"key":"pone.0349568.ref009","doi-asserted-by":"crossref","DOI":"10.1111\/j.1464-410X.2012.11337.x","article-title":"Systematic review of the impact of urinary tract infections on health-related quality of life","volume":"110","author":"SL Bermingham","year":"2012","journal-title":"BJU Int"},{"key":"pone.0349568.ref010","article-title":"Psychosocial burden of recurrent uncomplicated urinary tract infections","volume":"10","author":"KG Naber","year":"2022","journal-title":"GMS Infect Dis"},{"key":"pone.0349568.ref011","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1471-2296-15-162","article-title":"How women manage recurrent urinary tract infections: an analysis of postings on a popular web forum","volume":"15","author":"A Flower","year":"2014","journal-title":"BMC Fam Pract"},{"issue":"4","key":"pone.0349568.ref012","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3390\/ijms25042107","article-title":"Bacteriophages-Dangerous Viruses Acting Incognito or Underestimated Saviors in the Fight Against Bacteria?","volume":"25","author":"M Podlacha","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"pone.0349568.ref013","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/CU9.0000000000000268","article-title":"Bacteriophage therapy in women with chronic recurrent cystitis caused by multidrug-resistant bacteria: A prospective, observational, comparative study","volume":"19","author":"D Krakhotkin","year":"2025","journal-title":"Curr Urol"},{"issue":"1","key":"pone.0349568.ref014","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"M Sekhon","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"pone.0349568.ref015","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/add.15944","article-title":"The advantages and downsides of online focus groups for conducting research on addictive online behaviours","volume":"117","author":"M Flayelle","year":"2022","journal-title":"Addiction"},{"issue":"2","key":"pone.0349568.ref016","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"V Braun","year":"2006","journal-title":"Qual Res Psychol"},{"issue":"13","key":"pone.0349568.ref017","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample Size in Qualitative Interview Studies: Guided by Information Power","volume":"26","author":"K Malterud","year":"2016","journal-title":"Qual Health Res"},{"key":"pone.0349568.ref018","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/14780887.2020.1769238","article-title":"One size fits all? What counts as quality practice in (reflexive) thematic analysis?","volume":"18","author":"V Braun","year":"2021","journal-title":"Qual Res Psychol"},{"issue":"4","key":"pone.0349568.ref019","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/bjhp.12677","article-title":"Application of the theoretical framework of acceptability in a surgical setting: Theoretical and methodological insights","volume":"28","author":"C Paynter","year":"2023","journal-title":"Br J Health Psychol"},{"issue":"10","key":"pone.0349568.ref020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275576","article-title":"Application of the Theoretical Framework of Acceptability to assess a telephone-facilitated health coaching intervention for the prevention and management of type 2 diabetes","volume":"17","author":"L Timm","year":"2022","journal-title":"PLoS One"},{"issue":"7","key":"pone.0349568.ref021","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/ijerph22071139","article-title":"Exploration of Providers\u2019 Perceptions and Attitudes Toward Phage Therapy and Intentions for Future Adoption as an Alternative to Traditional Antibiotics in the US-A Cross-Sectional Study","volume":"22","author":"S Gandhi","year":"2025","journal-title":"Int J Environ Res Public Health"},{"key":"pone.0349568.ref022","author":"National Health and Medical Research Council (NHMRC)","year":"2006"},{"issue":"12","key":"pone.0349568.ref023","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jamainternmed.2021.6045","article-title":"FDA Drug Approval and the Ethics of Desperation","volume":"181","author":"EA Largent","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"2","key":"pone.0349568.ref024","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jacbts.2017.11.007","article-title":"Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the \u201cRight to Try\u201d","volume":"3","author":"GA Van Norman","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"pone.0349568.ref025","author":"National Institute for Health and Care Excellence (NICE)","year":"2022"},{"issue":"12","key":"pone.0349568.ref026","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2105\/AJPH.91.12.1929","article-title":"What is community? An evidence-based definition for participatory public health","volume":"91","author":"KM MacQueen","year":"2001","journal-title":"Am J Public Health"},{"issue":"11","key":"pone.0349568.ref027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205167","article-title":"Emergence of online communities: Empirical evidence and theory","volume":"13","author":"Y Dover","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"pone.0349568.ref028","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12913-022-07577-3","article-title":"Development of a theory-informed questionnaire to assess the acceptability of healthcare interventions","volume":"22","author":"M Sekhon","year":"2022","journal-title":"BMC Health Serv Res"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0349568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:22:12Z","timestamp":1779211332000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0349568"}},"subtitle":[],"editor":[{"given":"Awatif Abid","family":"Al-Judaibi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0349568","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}